| 200799-250MG |
|
NA |
(3aS,8aS)-4,4,8,8-Tetrakis(3,5-di-tert-butylphenyl)-6-hydroxy-2,2-bis(4-(trifluoromethyl)phenyl)tetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine
≥95%,99%e.e.
|
250MG |
C75H95F6O6P |
|
|
|
| 200799-100MG |
|
NA |
(3aS,8aS)-4,4,8,8-Tetrakis(3,5-di-tert-butylphenyl)-6-hydroxy-2,2-bis(4-(trifluoromethyl)phenyl)tetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine
≥95%,99%e.e.
|
100MG |
C75H95F6O6P |
|
|
|
| 200775-250MG |
|
NA |
(3aR,8aR)-4,4,8,8-Tetrakis(3,5-di-tert-butylphenyl)-6-hydroxy-2,2-bis(4-(trifluoromethyl)phenyl)tetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine
≥95%,99%e.e.
|
250MG |
C75H95F6O6P |
|
|
|
| 200775-100MG |
|
NA |
(3aR,8aR)-4,4,8,8-Tetrakis(3,5-di-tert-butylphenyl)-6-hydroxy-2,2-bis(4-(trifluoromethyl)phenyl)tetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine
≥95%,99%e.e.
|
100MG |
C75H95F6O6P |
|
|
|
| 200798-250MG |
|
NA |
(3aS,8aS)-4,4,8,8-Tetrakis(3,5-di-tert-butylphenyl)-2,2-bis(4-chlorophenyl)-6-hydroxy-tetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine
≥95%,99%e.e.
|
250MG |
C73H95Cl2O6P |
|
|
|
| 200798-100MG |
|
NA |
(3aS,8aS)-4,4,8,8-Tetrakis(3,5-di-tert-butylphenyl)-2,2-bis(4-chlorophenyl)-6-hydroxy-tetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine
≥95%,99%e.e.
|
100MG |
C73H95Cl2O6P |
|
|
|
| 200774-250MG |
|
NA |
(3aR,8aR)-4,4,8,8-Tetrakis(3,5-di-tert-butylphenyl)-2,2-bis(4-chlorophenyl)-6-hydroxy-tetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine
≥95%,99%e.e.
|
250MG |
C73H95Cl2O6P |
|
|
|
| 200774-100MG |
|
NA |
(3aR,8aR)-4,4,8,8-Tetrakis(3,5-di-tert-butylphenyl)-2,2-bis(4-chlorophenyl)-6-hydroxy-tetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine
≥95%,99%e.e.
|
100MG |
C73H95Cl2O6P |
|
|
|
| 200797-250MG |
|
NA |
(3aS,8aS)-4,4,8,8-Tetrakis(3,5-di-tert-butylphenyl)-2,2-bis(4-fluorophenyl)-6-hydroxy-tetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine
≥95%,99%e.e.
|
250MG |
C73H95F2O6P |
|
|
|
| 200797-100MG |
|
NA |
(3aS,8aS)-4,4,8,8-Tetrakis(3,5-di-tert-butylphenyl)-2,2-bis(4-fluorophenyl)-6-hydroxy-tetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine
≥95%,99%e.e.
|
100MG |
C73H95F2O6P |
|
|
|
| 200773-250MG |
|
NA |
(3aR,8aR)-4,4,8,8-Tetrakis(3,5-di-tert-butylphenyl)-2,2-bis(4-fluorophenyl)-6-hydroxy-tetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine
≥95%,99%e.e.
|
250MG |
C73H95F2O6P |
|
|
|
| 200773-100MG |
|
NA |
(3aR,8aR)-4,4,8,8-Tetrakis(3,5-di-tert-butylphenyl)-2,2-bis(4-fluorophenyl)-6-hydroxy-tetrahydro-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine
≥95%,99%e.e.
|
100MG |
C73H95F2O6P |
|
|
|
| 200796-250MG |
|
NA |
(3a'S,8a'S)-4',4',8',8'-Tetrakis(3,5-di-tert-butylphenyl)-6'-hydroxy-tetrahydrospiro[cyclohexane-1,2'-6'-ox[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine
≥95%,99%e.e.
|
250MG |
C66H97O6P |
|
|
|
| 200796-100MG |
|
NA |
(3a'S,8a'S)-4',4',8',8'-Tetrakis(3,5-di-tert-butylphenyl)-6'-hydroxy-tetrahydrospiro[cyclohexane-1,2'-6'-ox[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine
≥95%,99%e.e.
|
100MG |
C66H97O6P |
|
|
|
| 200772-250MG |
|
NA |
(3a'R,8a'R)-4',4',8',8'-Tetrakis(3,5-di-tert-butylphenyl)-6'-hydroxy-tetrahydrospiro[cyclohexane-1,2'-6'-ox[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine
≥95%,99%e.e.
|
250MG |
C66H97O6P |
|
|
|
| 200772-100MG |
|
NA |
(3a'R,8a'R)-4',4',8',8'-Tetrakis(3,5-di-tert-butylphenyl)-6'-hydroxy-tetrahydrospiro[cyclohexane-1,2'-6'-ox[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine
≥95%,99%e.e.
|
100MG |
C66H97O6P |
|
|
|
| 200795-250MG |
|
NA |
(3aS,8aS)-Tetrahydro-6-hydroxy-2,2-dimethyl-4,4,8,8-tetrakis(3,5-di-tert-butylphenyl)-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine
≥95%,99%e.e.
|
250MG |
C63H93O6P |
|
|
|
| 200795-100MG |
|
NA |
(3aS,8aS)-Tetrahydro-6-hydroxy-2,2-dimethyl-4,4,8,8-tetrakis(3,5-di-tert-butylphenyl)-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine
≥95%,99%e.e.
|
100MG |
C63H93O6P |
|
|
|
| 200771-250MG |
|
NA |
(3aR,8aR)-Tetrahydro-6-hydroxy-2,2-dimethyl-4,4,8,8-tetrakis(3,5-di-tert-butylphenyl)-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine
≥95%,99%e.e.
|
250MG |
C63H93O6P |
|
|
|
| 200771-100MG |
|
NA |
(3aR,8aR)-Tetrahydro-6-hydroxy-2,2-dimethyl-4,4,8,8-tetrakis(3,5-di-tert-butylphenyl)-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine
≥95%,99%e.e.
|
100MG |
C63H93O6P |
|
|
|
